Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 12,477,840 | 11,883,460 | 11,013,460 | 10,012,190 | 9,156,009 |
| Cost of Goods | 5,394,440 | 5,045,678 | 4,731,998 | 4,325,805 | 3,993,831 |
| Gross Profit | 7,083,400 | 6,837,784 | 6,281,462 | 5,686,389 | 5,162,178 |
| Operating Expenses | 3,965,910 | 3,988,036 | 3,665,398 | 3,304,290 | 3,018,802 |
| Operating Income | 3,117,930 | 2,850,424 | 2,617,062 | 2,382,900 | 2,144,207 |
| Interest Expense | 104,110 | 134,550 | 95,445 | 69,532 | 49,722 |
| Other Income | 226,770 | 234,072 | 147,933 | 81,951 | 72,205 |
| Pre-tax Income | 3,240,590 | 2,949,946 | 2,669,550 | 2,395,319 | 2,166,690 |
| Income Tax | 907,360 | 855,484 | 787,517 | 706,619 | 650,007 |
| Net Income Continuous | 2,334,353 | 2,094,462 | 1,882,033 | 1,688,700 | 1,516,683 |
| Net Income | $2,333,230 | $2,094,462 | $1,882,033 | $1,688,700 | $1,516,683 |
| EPS Basic Total Ops | 1.53 | 1.36 | 1.21 | 1.06 | 0.94 |
| EPS Basic Continuous Ops | 1.53 | 1.36 | 1.20 | 1.06 | 0.93 |
| EPS Diluted Total Ops | 1.50 | 1.36 | 1.21 | 1.06 | 0.94 |
| EPS Diluted Continuous Ops | 1.50 | 1.36 | 1.21 | 1.06 | 0.93 |
| EBITDA(a) | $3,902,170 | $3,578,178 | $3,303,146 | $2,949,323 | $2,654,710 |